Skip to Main Content

Paper Details

Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers.
Eur Urol Oncol
26
2018
Author NameAffiliation
Roberta FerraldeschiThe Institute of Cancer Research
Susana MirandaThe Institute of Cancer Research
Zafeiris ZafeiriouThe Institute of Cancer Research
Joaquin MateoThe Institute of Cancer Research
Raquel Perez-LopezThe Institute of Cancer Research
Adam SharpThe Institute of Cancer Research
Nina TunariuThe Institute of Cancer Research
Johann S de BonoThe Institute of Cancer Research
  • 1 - 8

Datasets

Release 1.2